手术前的认知功能和身体脆弱性预测了老年妇科瘤患者的决策满意度和术后坚持:一项前性观察研究
Celal Akdemir1, Merve Konal1, Mücahit Furkan Balcı2
1Department of Gynecologic Oncology, İzmir City Hospital, İzmir 35540, Türkiye.
Current oncology (Toronto, Ont.)
|February 26, 2026
概括
接受妇科癌症手术的老年人从评估认知功能和身体虚弱中受益. 较高的认知分数预示着更好的恢复和满意度,而脆弱表明更高的并发症风险.
科学领域:
- 老年医学 老年医学
- 手术瘤学手术瘤学
- 神经科学是一个神经科学.
背景情况:
- 预期寿命的增加导致更多的老年人接受妇科癌症手术.
- 术后康复和患者参与的预测因素对于这一群体至关重要.
- 认知功能和身体虚弱对以患者为中心的结果的影响需要进一步探索.
研究的目的:
- 研究术前认知功能和身体虚弱与术后康复和以患者为中心的结果在接受妇科癌症手术的老年女性之间的关联.
主要方法:
- 对68名65岁以上的女性进行前性观察性研究,这些女性因妇科恶性瘤而接受腹部手术.
- 使用蒙特利尔认知评估 (MoCA) 对认知功能的术前评估.
- 使用临床虚弱度量表 (CFS) 对身体虚弱的术前评估.
主要成果:
- 较高的MoCA分数与更早的动员,更短的住院时间,更好的术后坚持和更高的决策满意度相关.
- 较高的CFS分数与延迟康复和增加并发症率有关.
- 回归分析显示了手术前的认知功能,但没有身体脆弱,显著预测了手术后的坚持和决策满意度.
结论:
- 手术前的认知查可以预测以患者为中心的康复行为和接受妇科癌症手术的老年妇女的决策满意度.
- 在这个人群中,认知功能似乎是以患者为中心的结果的更重要的预测因素,而不是身体虚弱.
- 这些发现是探索性的,需要在更大的多中心研究中进行验证.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
282
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
282
Drug Dosing: Geriatric Patients
325
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
325
Peripheral Artery Disease V: Postoperative Nursing Management
462
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
462
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
764
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
764
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
272
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
272
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
299
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
299

